Results 161 to 170 of about 426,506 (312)
Sex Differences in Medication Discontinuation in Axial Spondyloarthritis
Objective We examined sex differences in medication discontinuation among patients with axial spondyloarthritis (axSpA) initiating tumor necrosis factor inhibitors (TNFi), interleukin‐17 inhibitors (IL‐17i), or JAK inhibitors (JAKi). Methods Using data from the Rheumatology Informatics System for Effectiveness (RISE) Registry (2003–2025), we assessed ...
Rachael Stovall +9 more
wiley +1 more source
Clinical trials for lupus nephritis. It is time for change. [PDF]
Morales E, Galindo M.
europepmc +1 more source
Objective Sjögren's disease is an autoimmune disorder that can impact multiple organ systems, including the peripheral nervous system (PNS). PNS manifestations, which can exist concurrently, include mononeuropathies, polyneuropathies, and autonomic nervous system neuropathies.
Anahita Deboo +88 more
wiley +1 more source
Reconsideration of Response Assessment in Obinutuzumab-Treated Membranous Nephropathy. [PDF]
Atay İ, Eröz E, Heybeli C.
europepmc +1 more source
Frequent achievement of a drug-free state after orthotopic liver transplantation [PDF]
Abu-Elmagd, K +11 more
core
Objective The goal was to assess the diagnostic performance of three novel autoantibodies (NA) for Sjögren disease (SjD) by comparing NA prevalence in patients with SjD, other autoimmune rheumatic diseases (ARDs), nonspecific chronic sialadenitis (CS), and controls.
Chadwick R. Johr +5 more
wiley +1 more source
Challenges and perspectives in xenoliver research: lessons from decedent and primate models. [PDF]
Hahn Z +3 more
europepmc +1 more source
History of organ transplantation via the two-way paradigm [PDF]
Demetris, AJ, Murase, N, Starzl, TE
core
RENAL HETEROTRANSPLANTATION FROM BABOON TO MAN: EXPERIENCE WITH 6 CASES. [PDF]
HITCHCOCK, CR +9 more
core +1 more source
Objective The purpose was to evaluate a biomarker score consisting of MUC5B rs35705950 promoter variant, plasma matrix metalloproteinase‐7 (MMP‐7), and serum anti–malondialdehyde‐acetaldehyde (anti‐MAA) antibody for rheumatoid arthritis (RA)–associated interstitial lung disease (ILD) risk stratification.
Kelsey Coziahr +16 more
wiley +1 more source

